Vertex Pharmaceuticals | VRTX - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q3 Sep/2025 4.88 4.80 Nov/09
FY2026Q2 Jun/2026 4.73 4.72 4.52 Aug/03
FY2026Q1 Mar/2026 4.47 4.43 4.06 May/04
FY2025Q4 Dec/2025 5.03 5.12 3.98 Feb/12
FY2025Q3 Sep/2025 4.80 4.62 4.38 Nov/03




Eps Alterar Data
AbbVie USD 3.65 1 2026-06
Acadia Pharmaceuticals USD 0.18 0.16 2026-06
Agios Pharmaceuticals USD -1.69 0 2026-06
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
Amgen USD 6.29 1.14 2026-06
Arrowhead Research USD -1.36 0.43 2026-06
Biogen USD 3.6 0.03 2026-06
BioMarin Pharmaceutical USD 1.2 0.44 2026-06
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Gilead Sciences USD -6.75 8.78 2026-06
Incyte USD 3.09 1.28 2026-06
Insmed USD -0.06 0.7 2026-06
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
J&J USD 2.9 0.2 2026-06
Merck USD -0.13 1.15 2026-06
Moderna USD -1.97 1.43 2026-06
Neurocrine Biosciences USD 2.85 0.91 2026-06
Novartis USD 2.41 0.42 2026-06
Pfizer USD 0.77 0.02 2026-06
PTC Therapeutics USD 0.92 0.95 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 14.29 4.82 2026-06
Roche Holding CHF 10.98 2.61 2026-06
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 2.09 0.21 2026-06
Sarepta Therapeutics USD 0.64 2.52 2026-06
Ultragenyx Pharmaceutical USD -0.9 0.94 2026-06
United Therapeutics USD 7.27 1.45 2026-06
Vertex Pharmaceuticals USD 4.73 0.26 2026-06